Encorafenib was approved by FDA recently for: (A) Prostate cancer, (B) Melanoma, (C) Small pox, (D) Chicken pox
Answer is B. It is a kinase inhibitor inhibiting thr BRAF gene which is responsible for gene mutations in melanoma